Evidence map›Paper›PMID 24558362›Full record

ArticlePloS one2014

Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors.

Dickson K Kirui, Juahua Mai, Anna-Lisa Palange, Guoting Qin, Anne L van de Ven, Xuewu Liu, Haifa Shen, Mauro Ferrari

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2018
    Article
  4. Inflammation and Cancer: In Medio Stat Nano.Current medicinal chemistry · 2018
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dickson K KiruiDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Juahua MaiDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Anna-Lisa PalangeDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Guoting QinDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Anne L van de VenDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Xuewu LiuDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America.
Haifa ShenDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America ; Department of Cell and Development Biology, Weill Cornell Medical College, New York, New York, United States of America.
Mauro FerrariDepartment of NanoMedicine, Houston Methodist Research Institute, Houston, Texas, United States of America ; Department of Internal Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Houston Methodist · USCornell University · US

Funding

Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2010 to 2014
$12.4M
TRANS-NETWORK PROJECTSU54CA143837 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2009 to 2014
$10.8M
NCI NIH HHS U54 CA143837NCI NIH HHS U54CA143837NCI NIH HHS U54 CA151668NCI NIH HHS U54CA151668
6 · The paper itself

Abstract

backgroundHyperthermia treatment has been explored as a strategy to overcome biological barriers that hinder effective drug delivery in solid tumors. Most studies have used mild hyperthermia treatment (MHT) to target the delivery of thermo-sensitive liposomes carriers. Others have studied its application to permeabilize tumor vessels and improve tumor interstitial transport. However, the role of MHT in altering tumor vessel interfacial and adhesion properties and its relationship to improved delivery has not been established. In the present study, we evaluated effects of MHT treatment on tumor vessel flow dynamics and expression of adhesion molecules and assessed enhancement in particle localization using mesoporous silicon vectors (MSVs). We also determined the optimal time window at which maximal accumulation occur.

resultsIn this study, using intravital microscopy analyses, we showed that temporal mild hyperthermia (∼1 W/cm(2)) amplified delivery and accumulation of MSVs in orthotopic breast cancer tumors. The number of discoidal MSVs (1000×400 nm) adhering to tumor vasculature increased 6-fold for SUM159 tumors and 3-fold for MCF-7 breast cancer tumors. By flow chamber experiments and Western blotting, we established that a temporal increase in E-selectin expression correlated with enhanced particle accumulation. Furthermore, MHT treatment was shown to increase tumor perfusion in a time-dependent fashion.

conclusionsOur findings reveal that well-timed mild hyperthermia treatment can transiently elevate tumor transport and alter vascular adhesion properties and thereby provides a means to enhance tumor localization of non-thermally sensitive particles such as MSVs. Such enhancement in accumulation could be leveraged to increase therapeutic efficacy and reduce drug dosing in cancer therapy.

Indexed as

AnimalsBlood VesselsBreast NeoplasmsEndothelial CellsErythrocytesE-SelectinFemaleHumansHyperthermia, InducedLiposomesMCF-7 CellsMiceMice, NudeMicroscopyNeoplasm TransplantationPerfusionE-SelectinLiposomesSilicon

Identifiers

PMID24558362
PMCPMC3928046
OpenAlexW1964220649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.